ECOD
F-group (family)

9.2.1.1 Avidin

Open in classification tree →Pfam PF01382 →

Ligands and drugs

1,084
Member domains
801
with ligand contacts (≤ 4 Å)
73.9% of members
688
with DrugDomain annotations
63.5% of members
507
with a DrugBank compound
46.8% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 9.2.1.1 belongs to X-group 9 Lipocalins/Streptavidin, which binds 9.3 ligand superclasses per 20 proteins, broader than 86% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00121BTNBiotin237
DB00141NAGN-Acetylglucosamine65
DB03549BNIBiotinyl P-Nitroaniline20
DB03353IMI2-Iminobiotin16
DB04650BTQ5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID8
DB03533GLLAcetyleneurea7
DB02406LEAN-Valeric Acid6
DB02674SNR4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid4
DB03112SHM6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid4
DB03139BH76-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid4
DB14189EDNEthylenediamine4
DB03775DTBDethiobiotin3
DB00396STRProgesterone2
DB07667DMB2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID2
DB07880HAB2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID2
DB08181MHB2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID2
DB08196MOB2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID2
DB08216MTB2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID2
DB08252NAB2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID2
DB01746DLED-Leucine1

Most frequently bound compounds

PDB ligandNameDomains in contact
BTNBIOTIN249
NAG2-acetamido-2-deoxy-beta-D-glucopyranose57
CLCHLORIDE ION25
BNI5-(2-OXO-HEXAHYDRO-THIENO[3,4-D]IMIDAZOL-6-YL)-PENTANOIC ACID (4-NITRO-PHENYL)-AMIDE20
KM3{N-(4-{bis[(pyridin-2-yl-kappaN)methyl]amino-kappaN}butyl)-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide}iron(3+)20
CUmetalCOPPER (II) ION16
IMI2-IMINOBIOTIN16
NAmetalSODIUM ION16
4IR{N-(4-{[2-(amino-kappaN)ethyl]sulfamoyl-kappaN}phenyl)-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide}(chloro)[(1,2,3,4,5-eta)-1,2,3,4,5-pentamethylcyclopentadienyl]iridium(III)15
HL95-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-(1-pyridin-4-ylpiperidin-4-yl)pentanamide15
MRD(4R)-2-METHYLPENTANE-2,4-DIOL15
MT6methyl 3-(4-oxo-4,5-dihydrofuro[3,2-c]pyridin-2-yl)benzoate13
ZOF6-({5-[(2E,3aS,4S,6aR)-2-iminohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}amino)hexanoic acid12
NOFtert-butyl 7'-[5-[(3aS,4S,6aR)-2-oxidanylidene-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-1-chloranyl-2,3,4,5,6-pentamethyl-spiro[1$l^{8}-iridapentacyclo[2.2.0.0^{1,3}.0^{1,5}.0^{2,6}]hexane-1,2'-3-aza-1-azonia-2$l^{8}-iridatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4,6,8(12),9-pentaene]-3'-carboxylate10
UJE5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-((S)-pyrrolidin-3-yl)pentanamide10
A1I7Y5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-(3-sulfanylphenyl)pentanamide9
P6GHEXAETHYLENE GLYCOL9
KFL6-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-(2,2,6,6-tetramethyl-1-oxidanyl-piperidin-4-yl)hexanamide8
LH45-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4- d]imidazolidin-4-yl]-N'-{2,6-bis[4-(morpholine-4- sulfonyl)phenyl]phenyl}pentanehydrazide8
NVZ5-[(3aS,4S,6aR)-1-acetyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid8